By Admin at 20 May 2016
Along with being less invasive and safer than surgical biopsy, the liquid biopsy is faster, returning results in just three days compared to four weeks for surgical biopsy. The liquid biopsy blood test was also able to correctly identify the genetic mutations every time, allowing the oncologists to select the best targeted treatment and avoid repeat biopsies.
By Admin at 16 May 2016
Together, U.S. and Russian researchers have identified several driver mutations for lung cancer, which they believe may be responsive to targeted therapies and immunotherapy.
By Admin at 13 May 2016
New research involving residents of Hong Kong found that long-term exposure to fine particles of air pollution—the type released from vehicles, power plants and manufacturing facilities—may increase your risk of dying from multiple types of cancer.
By Admin at 9 Mar 2016
Statins have been reported to reduce the incidence of lung cancer and also increase the survival of patients with lung cancer.
By Admin at 23 Nov 2015
Many are surprised that lung cancer is the leading cancer killer among women, because breast cancer is more common. However, although lung cancer is the second most common cancer (excluding skin cancer and trailing prostate cancer in men and breast cancer in women), it’s far deadlier than breast cancer.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial